*	OR T1 T2
R1	AND Arg1:T1 Arg2:T3	
R2	Has_qualifier Arg1:T5 Arg2:T6	
R3	Subsumes Arg1:T7 Arg2:T8	
*	OR T7 T9
R4	Has_qualifier Arg1:T9 Arg2:T10	
R5	Subsumes Arg1:T12 Arg2:T13	
T1	Condition 0 17	Contraindications
T2	Condition 31 47	hypersensitivity
T3	Procedure 104 126	epoetin beta treatment
T5	Condition 146 158	hypertension
T6	Qualifier 128 145	Poorly controlled
T7	Condition 203 225	Acute Myeloid Leukemia
T8	Condition 227 230	AML
T9	Observation 240 252	risk for AML
T10	Qualifier 235 239	high
T11	Competing_trial 254 367	Administration of another investigational drug within 1 month before screening or planned during the study period
T12	Condition 403 424	Pure Red Cell Aplasia
T13	Condition 426 430	PRCA
